Carbohydrate targets in HIV vaccine research: lessons from failures
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate targets in HIV vaccine research: lessons from failures
Authors
Keywords
-
Journal
Immunotherapy
Volume 1, Issue 5, Pages 777-794
Publisher
Future Medicine Ltd
Online
2009-09-02
DOI
10.2217/imt.09.44
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro
- (2010) F. D. TÓTH et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Residual Viraemia in HIV-1-Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers
- (2010) S. R. Ostrowski et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
- (2009) Johannes F. Scheid et al. NATURE
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation
- (2009) Gero Hütter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
- (2009) J. S. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- A brief history of HIV vaccine research: stepping back to the drawing board?
- (2008) Frank Miedema AIDS
- The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways
- (2008) A. A. Lambert et al. BLOOD
- Personalized Therapeutics: HIV Treatment in Adolescents
- (2008) NY Rakhmanina et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CCR5 as Target for HIV-1 Gene Therapy
- (2008) Reza Nazari et al. CURRENT GENE THERAPY
- Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells
- (2008) Neil C. Robson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens
- (2008) Maja A Sommerfelt et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120
- (2008) Alfredo Menendez et al. FASEB JOURNAL
- HIV/AIDS Vaccines: A Need for New Concepts?
- (2008) Marc P. Girard et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
- (2008) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication
- (2008) Maria B. Asparuhova et al. JOURNAL OF GENE MEDICINE
- Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120
- (2008) H. Chen et al. JOURNAL OF GENERAL VIROLOGY
- Why Do We Not Yet Have a Human Immunodeficiency Virus Vaccine?
- (2008) A. J. Levine JOURNAL OF VIROLOGY
- Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
- (2008) K. L. Davis et al. JOURNAL OF VIROLOGY
- Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency
- (2008) M. Vaccari et al. JOURNAL OF VIROLOGY
- Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point
- (2008) P. C. Matthews et al. JOURNAL OF VIROLOGY
- Failure of the Merck HIV vaccine: an uncertain step forward
- (2008) Merlin L Robb LANCET
- HIV immunopathogenesis and strategies for intervention
- (2008) Martin Cadogan et al. LANCET INFECTIOUS DISEASES
- Why vaccines are not the answer – The failure of V520 and the importance of cell-mediated immunity in the fight against HIV
- (2008) Aaron White MEDICAL HYPOTHESES
- CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection
- (2008) M Vaccari et al. Mucosal Immunology
- HIV immunology needs a new direction
- (2008) Ruslan Medzhitov et al. NATURE
- Challenges in the development of an HIV-1 vaccine
- (2008) Dan H. Barouch NATURE
- An HIV Vaccine — Challenges and Prospects
- (2008) Margaret I. Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
- (2008) J. G. Joyce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mise au point d’un vaccin prophylactique contre l’infection par le VIH. Où en est la recherche clinique?
- (2008) Z. Coutsinos et al. REVUE DE MEDECINE INTERNE
- A STEP into Darkness or Light?
- (2008) J. P. Moore et al. SCIENCE
- HIV Vaccine Research: The Way Forward
- (2008) A. S. Fauci et al. SCIENCE
- Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization
- (2008) Igor M. Belyakov et al. VIROLOGY
- Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins
- (2007) Mary Requena et al. IMMUNOLOGY
- Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells
- (2007) Nicolas Chomont et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search